Anthraquinone

Anthraquinone

SCHEMBL430600

CC(=O)C(C)=O.O=C1c2ccccc2C(=O)c2ccccc21

nearest known ligand 0.67

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.67
KMT2A Q03164 4/20 0.67
CDC25B P30305 2/20 0.67
BCL2 P10415 1/20 0.61
MCL1 Q07820 1/20 0.61
RAB9A P51151 7/20 0.59
ALDH1A1 P00352 7/20 0.59
NPC1 O15118 6/20 0.59
SMN1; SMN2 Q16637 6/20 0.59
MAPT P10636 5/20 0.59
MAOA P21397 3/20 0.59
ELANE P08246 1/20 0.56
TTR P02766 1/20 0.56
LMNA P02545 3/20 0.55
MAPK1 P28482 3/20 0.55
POLB P06746 3/20 0.55
APAF1 O14727 2/20 0.55
TDP2 O95551 2/20 0.55
S100A4 P26447 2/20 0.55
KDM4E B2RXH2 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Anthraquinone SCHEMBL11698233 0.92 MEN1 (0.71) MEN1KMT2ACDC25BBCL2MCL1
Anthraquinone SCHEMBL27674413 0.89 MEN1 (0.67) MEN1KMT2ACDC25BBCL2MCL1
Anthraquinone SCHEMBL11302120 0.85 CDC25B (0.80) MEN1KMT2ACDC25BBCL2MCL1
Anthraquinone SCHEMBL28771776 0.84 MEN1 (0.60) MEN1KMT2ACDC25BBCL2MCL1
SCHEMBL14273442 0.84 MEN1 (0.52) MEN1KMT2ACDC25BBCL2MCL1
Anthraquinone SCHEMBL10902508 0.83 MEN1 (0.67) MEN1KMT2ACDC25BBCL2MCL1
Anthraquinone SCHEMBL7856851 0.82 MEN1 (0.57) MEN1KMT2ACDC25BBCL2MCL1
Anthraquinone SCHEMBL5958714 0.82 CDC25B (0.86) MEN1KMT2ACDC25BBCL2MCL1
Anthraquinone SCHEMBL183074 0.82 MEN1 (0.86) MEN1KMT2ACDC25BBCL2MCL1
Anthraquinone SCHEMBL1901249 0.82 MEN1 (1.00) MEN1KMT2ACDC25BBCL2MCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103025340-B Aloe vera composition and its use in preparing medicaments for anti-viral and treating Acquired Immune Deficiency Syndrome (AIDS) NORTH TEXAS MEDICAL ASS 2014-12-24 CN claimed
EP-2595643-A1 ANTI-VIRAL PROPERTIES OF ALOE VERA AND ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS) TREATMENT North Texas Medical Associates (US) 2013-05-29 EP claimed
CN-103025340-A Antiviral properties of Aloe vera and treatment of Acquired Immune Deficiency Syndrome (AIDS) NORTH TEXAS MEDICAL ASS 2013-04-03 CN claimed
US-20120022018-A1 ANTI-VIRAL PROPERTIES OF ALOE VERA AND ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS) TREATMENT NORTH TEXAS MEDICAL ASSOCIATES (US) 2012-01-26 US claimed
WO-2012012513-A1 ANTI-VIRAL PROPERTIES OF ALOE VERA AND ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS) TREATMENT NORTH TEXAS MEDICAL ASSOCIATES (US) 2012-01-26 WO claimed
EP-0002321-B1 PHOTOPOLYMERISABLE ELEMENTS AND A PROCESS FOR THE PRODUCTION OF PRINTING PLATES THEREFROM BEXFORD LIMITED (GB) 1981-10-28 EP claimed
US-4289843-A AROMATIC OXOAMINE INITIATOR BEXFORD LIMITED (GB) 1981-09-15 US claimed
EP-0002321-A2 Photopolymerisable elements and a process for the production of printing plates therefrom BEXFORD LIMITED (GB) 1979-06-13 EP claimed
CN-103025340-B Aloe vera composition and its use in preparing medicaments for anti-viral and treating Acquired Immune Deficiency Syndrome (AIDS) NORTH TEXAS MEDICAL ASS 2014-12-24 CN disclosed
EP-2595643-A1 ANTI-VIRAL PROPERTIES OF ALOE VERA AND ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS) TREATMENT North Texas Medical Associates (US) 2013-05-29 EP disclosed
CN-103025340-A Antiviral properties of Aloe vera and treatment of Acquired Immune Deficiency Syndrome (AIDS) NORTH TEXAS MEDICAL ASS 2013-04-03 CN disclosed
US-20120022018-A1 ANTI-VIRAL PROPERTIES OF ALOE VERA AND ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS) TREATMENT NORTH TEXAS MEDICAL ASSOCIATES (US) 2012-01-26 US disclosed
WO-2012012513-A1 ANTI-VIRAL PROPERTIES OF ALOE VERA AND ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS) TREATMENT NORTH TEXAS MEDICAL ASSOCIATES (US) 2012-01-26 WO disclosed
CN-1046700-C Reduction of the sennoside mixture to the corresponding anthrone compounds MADAUS AG (DE) 1999-11-24 CN disclosed
CN-1088571-A The preparation method of diacetyl rhein MADAUS AG (DE) 1994-06-29 CN disclosed
EP-0017336-B1 PHOTOPOLYMERISABLE ELEMENTS, AND RELIEF PRINTING PLATES MADE THEREFROM BEXFORD LIMITED (GB) 1983-10-12 EP disclosed
US-4315066-A ADHESIVES OF AN UNSATURATED POLYESTER OF MALEIC ACID AND AN ALKOXYLATED BISPHENOL A; PHOTORESISTS BEXFORD LIMITED (GB) 1982-02-09 US disclosed
EP-0002321-B1 PHOTOPOLYMERISABLE ELEMENTS AND A PROCESS FOR THE PRODUCTION OF PRINTING PLATES THEREFROM BEXFORD LIMITED (GB) 1981-10-28 EP disclosed
US-4289843-A AROMATIC OXOAMINE INITIATOR BEXFORD LIMITED (GB) 1981-09-15 US disclosed
EP-0017336-A1 Photopolymerisable elements, and relief printing plates made therefrom BEXFORD LIMITED (GB) 1980-10-15 EP disclosed